| Q88687424 | 90Y Resin Microspheres Radioembolization for Colon Cancer Liver Metastases Using Full-Strength Contrast Material |
| Q45207818 | 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study |
| Q39368661 | A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal Metastases |
| Q38169587 | A systematic review on the safety and efficacy of yttrium-90 radioembolization for unresectable, chemorefractory colorectal cancer liver metastases. |
| Q46657713 | Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases |
| Q37131705 | Administered activity and outcomes of glass versus resin (90)Y microsphere radioembolization in patients with colorectal liver metastases |
| Q38230654 | Advances in understanding of colorectal liver metastasis and implications for the clinic |
| Q37890914 | Arterial therapies of colorectal cancer metastases to the liver |
| Q37711918 | Clinical Interventional Oncology Symposium And Integrative Healthcare Symposium |
| Q37308725 | Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). |
| Q34663557 | Colorectal hepatic metastasis: Evolving therapies |
| Q38353727 | Comparative effectiveness in hepatic malignancies |
| Q38001351 | Comprehensive review of the diagnosis and treatment of biliary tract cancer 2012. Part II: multidisciplinary management |
| Q35776233 | Curative strategies for liver metastases from colorectal cancer: a review |
| Q64941039 | Current role of transarterial chemoembolization and radioembolization in the treatment of metastatic colorectal cancer. |
| Q26744307 | Current status of transarterial radioembolization |
| Q38831025 | Current strategies in interventional oncology of colorectal liver metastases |
| Q50850008 | Cytokines and 90Y-Radioembolization: Relation to Liver Function and Overall Survival. |
| Q36697911 | Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheres |
| Q53043230 | Early post-treatment FDG PET predicts survival after 90Y microsphere radioembolization in liver-dominant metastatic colorectal cancer. |
| Q35691040 | Early survival prediction after intra-arterial therapies: a 3D quantitative MRI assessment of tumour response after TACE or radioembolization of colorectal cancer metastases to the liver. |
| Q51456829 | Evaluation of Surefire's precision direct-to-tumor embolization device to augment therapeutic response to intra-arterial, liver-directed therapies for patients with primary and secondary liver cancers. |
| Q38073796 | Exploiting microspheres as a therapeutic proficient doer for colon delivery: a review. |
| Q57300379 | Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases |
| Q36656612 | Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies |
| Q36352452 | Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases |
| Q55283883 | Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know. |
| Q36080625 | Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience |
| Q37996428 | Integration of radioembolisation into multimodal treatment of liver-dominant metastatic colorectal cancer |
| Q38757170 | Interventional radiology and the care of the oncology patient |
| Q38179343 | Intra-arterial therapies for metastatic colorectal cancer |
| Q42125152 | Intra-arterial treatment of liver metastases from colorectal carcinoma |
| Q64278718 | Literature Review of Current Management of Colorectal Liver Metastasis |
| Q38246198 | Liver resection for metastatic disease after y90 radioembolization: a case series with long-term follow-up |
| Q38256165 | Liver-directed therapies in metastatic colorectal cancer |
| Q30415022 | Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements |
| Q38206730 | Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review |
| Q53746693 | Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary. |
| Q38811107 | Management of patients with colorectal liver metastasis in eleven questions and answers |
| Q36392298 | Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data |
| Q90681620 | Metastatic appendiceal cancer treated with Yttrium 90 radioembolization and systemic chemotherapy: A case report |
| Q35028984 | Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres |
| Q33779859 | Multidisciplinary approach of colorectal cancer liver metastases |
| Q38398883 | Non-operative therapies for colorectal liver metastases |
| Q33594891 | Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation |
| Q47550727 | Outcomes of Radioembolization in Patients with Chemorefractory Colorectal Cancer Liver Metastasis: a Single-Center Experience. |
| Q33618754 | PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases. |
| Q33918145 | Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer |
| Q46678373 | Phase I/II Trial of Anticarcinoembryonic Antigen Radioimmunotherapy, Gemcitabine, and Hepatic Arterial Infusion of Fluorodeoxyuridine Postresection of Liver Metastasis for Colorectal Carcinoma. |
| Q47112804 | Pretreatment albumin may aid in patient selection for intrahepatic Y-90 microsphere transarterial radioembolization (TARE) for malignancies of the liver |
| Q37525319 | Pretreatment tumor volume as a prognostic factor in metastatic colorectal cancer treated with selective internal radiation to the liver using yttrium-90 resin microspheres |
| Q48254405 | Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential |
| Q53076171 | Radiation-induced liver damage: correlation of histopathology with hepatobiliary magnetic resonance imaging, a feasibility study. |
| Q37326857 | Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes |
| Q38813248 | Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial? |
| Q64999668 | Radioembolization as an adjunct therapy to the resection of liver tumors. |
| Q44166434 | Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients |
| Q35564038 | Radioembolization for primary and metastatic liver cancer. |
| Q50231522 | Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes. |
| Q33820777 | Radioembolization of hepatic tumors |
| Q37525291 | Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study |
| Q38658289 | Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases. |
| Q87185931 | Recurrence location after resection of colorectal liver metastases influences prognosis |
| Q40510233 | Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies |
| Q94602760 | Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm |
| Q41762717 | Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla |
| Q35230366 | Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer |
| Q38577785 | Safety of redo hepatectomy for colorectal liver metastases after selective interarterial radiation therapy: a case report. |
| Q37316201 | Selective Interarterial Radiation Therapy (SIRT) in Colorectal Liver Metastases: How Do We Monitor Response? |
| Q38283680 | Selective internal radiation therapy dosimetry |
| Q53026517 | Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy. |
| Q36605013 | Semi-Quantitative Analysis of Post-Transarterial Radioembolization (90)Y Microsphere Positron Emission Tomography Combined with Computed Tomography (PET/CT) Images in Advanced Liver Malignancy: Comparison With (99m)Tc Macroaggregated Albumin (MAA) S |
| Q52670580 | Single-institution experience with selective internal radiation therapy (SIRT) for the treatment of unresectable colorectal liver metastases. |
| Q45128821 | Standards of practice in transarterial radioembolization. |
| Q38182093 | The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review. |
| Q38283666 | The evidence for resection post-selective internal radiation therapy |
| Q38664762 | The state of regional therapy in the management of metastatic colorectal cancer to the liver |
| Q38192781 | Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature |
| Q40257307 | Transarterial chemoembolisation in hepatocellular carcinoma |
| Q61810602 | Transarterial radioembolization with Iodine-131-Lipiodol for hepatic metastases from gastrointestinal malignancies - Experience in tertiary care oncology center in India |
| Q36083302 | Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system |
| Q50331836 | Yttrium-90 microsphere selective internal radiation therapy for liver metastases following systemic chemotherapy and surgical resection for metastatic adrenocortical carcinoma |
| Q40128585 | Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival. |
| Q38239688 | Yttrium-90 radioembolization of hepatic metastases from colorectal cancer |